Intelligent Biopsy Platform with Adaptive Aspiration and Real-time Tissue Analysis

A next-generation biopsy device that integrates AI-driven navigation, real-time tissue analysis, and adaptive aspiration to optimize sample quality, minimize tissue damage, and enable personalized tissue engineering and regeneration therapies.

The original biopsy device with aspiration valve, as described in the original patent, has limitations in terms of sample quality and tissue damage. The new inventive concept addresses these limitations by introducing an adaptive aspiration valve that dynamically adjusts suction pressure based on real-time tissue sampling data, ensuring optimal sample quality and minimizing tissue damage.

The intelligent biopsy platform consists of an adaptive aspiration valve that adjusts suction pressure in real-time based on tissue sampling data, an AI-driven navigation system for precise and efficient sampling, a real-time tissue analysis system with integrated spectrometer and machine learning-based classification algorithm, and a modular design with interchangeable instrument sets and drive units. The platform also features an integrated 3D printing module for in-situ creation of customized tissue scaffolds and implants.

The new claims introduce a paradigm shift in biopsy technology by integrating AI-driven navigation, real-time tissue analysis, and adaptive aspiration, making the original inventive concept obsolete. The inventive step lies in the dynamic adjustment of suction pressure based on real-time tissue sampling data, enabling optimal sample quality and minimizing tissue damage.

Alternative embodiments of the inventive concept could include variations in the AI-driven navigation system, such as using different machine learning algorithms or incorporating additional sensors. The real-time tissue analysis system could be modified to include additional analytical techniques, such as Raman spectroscopy or fluorescence microscopy. The modular design could be adapted for use in different medical specialties or applications.

The intelligent biopsy platform has significant commercial potential in the medical device industry, particularly in the fields of oncology, neurology, and orthopedics. The platform's ability to optimize sample quality, minimize tissue damage, and enable personalized tissue engineering and regeneration therapies could revolutionize the field of diagnostic medicine and tissue sampling.